Lukas Hainz

Lukas Hainz

Biopharma Innovation Specialist
Lukas Hainz specializes in biopharmaceutical research and development. He unpacks research from clinical trials and explores regulatory affairs implications on the pharmaceutical industry, focusing on innovative therapies and patent development.
Can Ozempic Interfere With Cancer Detection in Scans?
Tech & Innovation Can Ozempic Interfere With Cancer Detection in Scans?

In a startling revelation that has caught the attention of the medical community, a popular medication used for weight loss and diabetes management, Ozempic, may pose an unexpected challenge in the realm of diagnostic imaging. Known for its effectiveness in controlling blood sugar and aiding

Can Tecvayli Redefine Early Treatment for Multiple Myeloma?
Research & Development Can Tecvayli Redefine Early Treatment for Multiple Myeloma?

In the quiet corridors of cancer research, a seismic shift is stirring for those battling multiple myeloma, a blood cancer that relentlessly challenges both patients and clinicians, igniting hope for a breakthrough. Picture a patient, exhausted after rounds of treatment, hoping for a breakthrough

Skyline College Bio Club Shines at Club Blitz Event
Biotech & Bioprocessing Skyline College Bio Club Shines at Club Blitz Event

Today, we’re thrilled to sit down with Ivan Kairatov, a renowned biopharma expert with extensive experience in research, development, and innovation within the biotechnology industry. With a deep understanding of the latest technologies and trends, Ivan offers invaluable insights into the world of

InfEHR: Revolutionizing Diagnosis with AI-Powered EHR Analysis
Tech & Innovation InfEHR: Revolutionizing Diagnosis with AI-Powered EHR Analysis

In an era where healthcare is becoming increasingly data-driven, a groundbreaking artificial intelligence system known as InfEHR (Inference on Electronic Health Records) is poised to redefine medical diagnostics with unprecedented precision. Developed through a collaboration led by researchers at

MMA Warns Against Corporate Overreach in Malaysian Healthcare
Research & Development MMA Warns Against Corporate Overreach in Malaysian Healthcare

In a landscape where healthcare should prioritize patient well-being above all, the Malaysian Medical Association (MMA) has raised a critical alarm about the increasing influence of corporate entities on medical decisions, threatening the ethical foundation of the profession. As articulated by its

Whole Genome Sequencing Could Transform Breast Cancer Care
Research & Development Whole Genome Sequencing Could Transform Breast Cancer Care

Breast cancer remains a significant global health challenge, affecting millions of lives with its high prevalence and mortality rates, as evidenced by over 2.3 million women diagnosed worldwide in a single year and nearly 670,000 deaths. This alarming reality highlights the urgent need for

Can AI Predict Future Knee X-Rays for Better Osteoarthritis Care?
Tech & Innovation Can AI Predict Future Knee X-Rays for Better Osteoarthritis Care?

What if a glimpse into the future could save millions from the crippling pain of osteoarthritis, a condition affecting over 500 million people worldwide? Picture a tool that shows how a knee joint might look a year from now, revealing the silent progression of this debilitating disease. This isn't

Can Affordable Robots Transform Bioanalytical Labs?
Tech & Innovation Can Affordable Robots Transform Bioanalytical Labs?

In the dynamic realm of bioanalytical research, where precision and efficiency underpin every breakthrough, smaller laboratories often grapple with a significant obstacle: the prohibitive cost of automation technology. These facilities, crucial to pharmaceutical advancements through the meticulous

Wearable Tech Breakthrough Enhances Cough Detection Accuracy
Tech & Innovation Wearable Tech Breakthrough Enhances Cough Detection Accuracy

In a world where chronic respiratory conditions like asthma affect millions, the ability to monitor symptoms in real-time could be a lifeline, and recent advancements in wearable technology are making this a reality with unprecedented precision. Researchers from North Carolina State University (NC

CGT Manufacturing Innovation – Review
Biotech & Bioprocessing CGT Manufacturing Innovation – Review

Imagine a world where life-altering treatments for devastating conditions like glioblastoma or ovarian cancer are not just a scientific breakthrough but are accessible to every patient in need, regardless of location or financial means. This vision, though tantalizingly close in 2025, remains out

Loading
Latest Articles

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later